Brinker Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,562
Closed -$354K 1000
2019
Q3
$354K Buy
3,562
+56
+2% +$5.32K 0.01% 779
2019
Q2
$324K Sell
3,506
-181
-5% -$17.2K 0.01% 800
2019
Q1
$348K Sell
3,687
-961
-21% -$84K 0.01% 767
2018
Q4
$298K Sell
4,648
-7,407
-61% -$547K 0.01% 740
2018
Q3
$1.08M Sell
12,055
-28,983
-71% -$2.56M 0.04% 479
2018
Q2
$3.26M Sell
41,038
-1,950
-5% -$162K 0.12% 166
2018
Q1
$3.83M Buy
42,988
+3,566
+9% +$342K 0.15% 144
2017
Q4
$4.11M Sell
39,422
-4,201
-10% -$474K 0.16% 138
2017
Q3
$6.36M Sell
43,623
-3,934
-8% -$536K 0.26% 76
2017
Q2
$6.18M Buy
47,557
+5,422
+13% +$664K 0.29% 78
2017
Q1
$5.24M Buy
42,135
+7,608
+22% +$910K 0.24% 83
2016
Q4
$4M Buy
+34,527
New +$3.85M 0.22% 103

Other funds holding CELG

Brinker Capital's CELG Position: Q4 2019 in Review

Brinker Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,562 shares — an estimated $354K sold.

Brinker Capital first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $6.36M in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Brinker Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Brinker Capital sold 3,562 Celgene Corp shares in Q4 2019, an estimated $354K.
  • Brinker Capital first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Brinker Capital's Celgene Corp position peaked at $6.36M in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Brinker Capital's 13F filing for Q4 2019, filed 18 Feb 2020.